Does breakfast change how this pain drug works? new study investigates

NCT ID NCT07487740

Recruiting now Knowledge-focused Sponsor: Trevi Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial is testing whether eating a high-fat, high-calorie meal changes how the body absorbs nalbuphine extended-release tablets. Sixty healthy volunteers will take the drug once with food and once without, and researchers will compare drug levels in their blood. The study is not designed to treat any condition, but to gather information for future use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

nalbuphine extended-release tablets

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY PARTICIPANTS

Contacts and locations

Show contact details

Locations

Clinical Pharmacology of Miami, LLC.
RECRUITING

Miami, Florida, 33172, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••